Mymetics Corporation

Mymetics Corporation: The First Human Vaccinations of Mymetics’ Preventative HIV Vaccine Candidate are Well Tolerated

Mymetics Corporation: The First Human Vaccinations of Mymetics’ Preventative HIV Vaccine Candidate are Well Tolerated

Mymetics Corporation Presents Ground Breaking Results With Preventative HIV Vaccine at the World AIDS Vaccine Congress in Paris 19 – 22 October

Mymetics Corporation Presents Ground Breaking Results With Preventative HIV Vaccine at the World AIDS Vaccine Congress in Paris 19 – 22 October

Mymetics Corporation Announces the Appointment of Dr. Stanley Plotkin as Chairman of the Scientific Advisory Board and Election of New Members

Mymetics Corporation Announces the Appointment of Dr. Stanley Plotkin as Chairman of the Scientific Advisory Board and Election of New Members

Southtrade Asset Solutions, Inc. hat ein formales Angebot fuer einen Unternehmenskauf von Rushh Europe AG vorgelegt

Southtrade Asset Solutions, Inc. hat ein formales Angebot für einen Unternehmenskauf von Rushh Europe AG vorgelegt

Mymetics Corporation’s Board of Directors Announces the Appointment of Jacques-Francois Martin as President and CEO

Mymetics Corporation’s Board of Directors Announces the Appointment of Jacques-Francois Martin as President and CEO

Mymetics Corporation Completes Important Acquisition

Mymetics Corporation Completes Important Acquisition

Mymetics Corporation Acquires Virosome Biologicals B.V.

Mymetics Corporation Acquires Virosome Biologicals B.V.

Press Release

Press Release

Mymetics Corporation Announces Success of Its Preventive Vaccine Against HIV/AIDS and Commencement of European Phase 1 Human Clinical Trials

Mymetics Corporation Announces Success of Its Preventive Vaccine Against HIV/AIDS and Commencement of European Phase 1 Human Clinical Trials